| Literature DB >> 34941664 |
Hisham Ahmed Imad1,2, Aishath Azna Ali3, Mariyam Nahuza3, Rajan Gurung3, Abdulla Ubaid3, Aishath Maeesha4, Sariu Ali Didi4, Rajib Kumar Dey4, Abdullah Isneen Hilmy4,5, Aishath Hareera6, Ibrahim Afzal6, Wasin Matsee7, Wang Nguitragool1,8, Emi E Nakayama2, Tatsuo Shioda2.
Abstract
Scrub typhus is a neglected tropical disease predominantly occurring in Asia. The causative agent is a bacterium transmitted by the larval stage of mites found in rural vegetation in endemic regions. Cases of scrub typhus frequently present as acute undifferentiated febrile illness, and without early diagnosis and treatment, the disease can develop fatal complications. We retrospectively reviewed de-identified data from a 23-year-old woman who presented to an emergency department with complaints of worsening abdominal pain. On presentation, she appeared jaundiced and toxic-looking. Other positive findings on abdominal examination were a positive Murphey's sign, abdominal guarding and hepatosplenomegaly. Magnetic resonance cholangiopancreatography demonstrated acalculous cholecystitis. Additional findings included eschar on the medial aspect of the left thigh with inguinal regional lymphadenopathy. Further, positive results were obtained for immunoglobulins M and G, confirming scrub typhus. The workup for other infectious causes of acute acalculous cholecystitis (AAC) detected antibodies against human herpesvirus 4 (Epstein-Barr virus), suggesting an alternative cause of AAC. Whether that represented re-activation of the Epstein-Barr virus could not be determined. As other reports have described acute acalculous cholecystitis in adult scrub typhus patients, we recommend doxycycline to treat acute acalculous cholecystitis in endemic regions while awaiting serological confirmation.Entities:
Keywords: Epstein–Barr virus; Maldives; Orientia tsutsgugamushi; acute acalculous cholecystitis; clinical manifestation; eschar; re-activation; scrub typhus
Year: 2021 PMID: 34941664 PMCID: PMC8707333 DOI: 10.3390/tropicalmed6040208
Source DB: PubMed Journal: Trop Med Infect Dis ISSN: 2414-6366
Laboratory Results at Presentation and Before Discharge.
| Day of Illness (Days) | 9 | 14 |
|---|---|---|
| Leukocyte/µL | 6650 | 8030 |
| Neutrophils/µL | 4788 | 4496 |
| Lymphocytes/µL | 1349 | 2328 |
| Monocytes/µL | 435 | 1003 |
| Eosinophils/µL | 0 | 24 |
| Basophils/µL | 0 | 0 |
| Platelets/µL | 269,000 | 545,000 |
| Hemoglobin (g/dL) | 10.6 | 7.8 |
| Hematocrit (%) | 32.9 | 24.6 |
| Total Bilirubin (mg/dL) | 4.7 | 3.5 |
| Direct Bilirubin (mg/dL) | 3.5 | 2.6 |
| Total protein (g/dL) | 6.9 | 6.8 |
| Albumin (g/dL) | 3.4 | 2.8 |
| Alkaline phosphatase (IU/L) | 288 | 250 |
| Aspartate aminotransferase (IU/L) | 140 | 76 |
| Alanine aminotransferase (IU/L) | 157 | 93 |
| Creatinine (mg/dL) | 0.8 | 0.6 |
| Urea (mg/dL) | 10 | 6.4 |
| CRP (mg/dL) | 7.7 | 2.8 |
| Sodium (mmol/L) | 131 | 134 |
| Potassium (mmol/L) | 4.5 | 4.3 |
| Ferritin (ng/mL) | 1299.3 | |
| LDH (IU/L) | 726 | |
| EBV-VCA IgM (IU/mL) | 63.6 | |
| EBV-VCA IgG (IU/mL) | 89.9 | |
| EBV-EA IgG (IU/mL) | 16.1 | |
| EBV-NA IgG (IU/mL) | 574.0 | |
| Blood culture | no growth | |
| positive | ||
| positive |
CRP: C-reactive protein, LDH: lactate dehydrogenase, EBV-VCA: Epstein–Barr virus viral capsid antigen, EBV-EA; Epstein–Barr virus early antigen, EBV-NA: Epstein–Barr virus nuclear antigen, IgM: immunoglobulin M, IgG: immunoglobulin G.
Figure 1Imaging of the abdomen during hospitalization. (a) Coronal-view CT of the abdomen shows hepatosplenomegaly. (b) Axial-view CT of the abdomen demonstrates cholecystitis with enhancement of the gallbladder wall. (c) Longitudinal ultrasonography depicts an edematous gallbladder wall (wall thickness > 4 mm) without lithiasis. (d) Magnetic resonance cholangiopancreatography reveals a ballooned gallbladder without any ductal obstruction, but with signs of inflammation consistent with acalculous cholecystitis.